TLR7 and HIV infectious disease: While these findings suggest a mechanism for HIV persistence and latency in macrophages and microglial cells, they also indicate the importance and necessity to determine whether to immunologically activate intracellular innate immunity by imiquimod, a TLR7 agonist, to protect macrophages from HIV infection and suppress the viral replication.